WuXi Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
WuXi Biologics (2269)
WuXi Biologics stock price live, this page displays HK 2269 stock exchange data. View the 2269 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the WuXi Biologics real time stock price chart below.
What Is the WuXi Biologics Stock Price Today?
The WuXi Biologics stock price today is 36.58.
What Is the Stock Symbol for WuXi Biologics?
The stock symbol for WuXi Biologics is ""2269.""
What Stock Exchange Does WuXi Biologics Trade On?
WuXi Biologics is listed and trades on the Hong Kong stock exchange.
Is WuXi Biologics a Good Stock to Buy?
Determining whether WuXi Biologics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2269 quote. (ISIN: KYG970081173)
What Is the WuXi Biologics Stock Price Today?
The WuXi Biologics stock price today is 36.58.
What Is the Stock Symbol for WuXi Biologics?
The stock symbol for WuXi Biologics is ""2269.""
What Stock Exchange Does WuXi Biologics Trade On?
WuXi Biologics is listed and trades on the Hong Kong stock exchange.
Is WuXi Biologics a Good Stock to Buy?
Determining whether WuXi Biologics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2269 quote. (ISIN: KYG970081173)
36.58
+0.84(+2.35%)
Closed·
Fair Value
An estimate of a WuXi Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
35.58
37.00
52 wk Range
10.36
37.44
2269 Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
2269 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a WuXi Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
35.5837.00
52 wk Range
10.3637.44
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2269 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a WuXi Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
37.10
Upside
+1.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- WuXi Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - WuXi Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - WuXi Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- WuXi Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - WuXi Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - WuXi Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - WuXi Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
WuXi Biologics Company Profile
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and engages in investment and material supplier activities. It has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Compare 2269 to Peers and Sector
Metrics to compare | 2269 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2269PeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.5x | −0.7x | −0.6x | |
PEG Ratio | 0.50 | 0.10 | 0.00 | |
Price/Book | 3.0x | 2.4x | 2.6x | |
Price / LTM Sales | 6.8x | 4.0x | 3.3x | |
Upside (Analyst Target) | −1.1% | 27.4% | 39.1% | |
Fair Value Upside | Unlock | 11.1% | 5.3% | Unlock |
Analyst Ratings
25 Buy
5 Hold
0 Sell
Ratings:
30 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 37.10
(+1.41% Upside)
Earnings
Latest Release
Aug 19, 2025
EPS / Forecast
0.55 / --
Revenue / Forecast
9.95B / --
People Also Watch
FAQ
What Stock Exchange Does WuXi Biologics Trade On?
WuXi Biologics is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for WuXi Biologics?
The stock symbol for WuXi Biologics is "2269."
What Is the WuXi Biologics Market Cap?
As of today, WuXi Biologics market cap is 148.90B.
What Is WuXi Biologics's Earnings Per Share (TTM)?
The WuXi Biologics EPS (TTM) is 1.04.
From a Technical Analysis Perspective, Is 2269 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has WuXi Biologics Stock Split?
WuXi Biologics has split 1 times.
How Many Employees Does WuXi Biologics Have?
WuXi Biologics has 12552 employees.
What is the current trading status of WuXi Biologics (2269)?
As of 03 Sept 2025, WuXi Biologics (2269) is trading at a price of 36.58, with a previous close of 36.58. The stock has fluctuated within a day range of 35.58 to 37.00, while its 52-week range spans from 10.36 to 37.44.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.